Tonghua Dongbao Pharmaceutical Co Ltd

In 2023, China was the second largest product/technology exporter in the global biopharmaceutical pipeline, with 143 pipeline transactions, runner up only to the US. In China’s biopharmaceutical indus

Going into the third year of the global pandemic, residents of China's largest city are feeling uncertainty around potential extended lockdowns for the first time, the impact of which could affect a m

Going into the third year of the global pandemic, residents of China's largest city are feeling uncertainty around potential extended lockdowns for the first time, the impact of which could affect a m

As the world’s second-largest single country pharma market, China has leveraged its size in exchange for pricing concessions from international drug makers, pitting them against domestic players in a